Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

iAnthus gets New York green light for Valley Agriceuticals deal

Stockhouse Editorial
0 Comments| August 3, 2017

{{labelSign}}  Favorites
{{errorMessage}}

iAnthus Capital Holdings Inc. (CSE: C.IAN, OTCQB: ITHUF, Forum) on Thursday said the New York State Department of Health has approved the company’s proposed acquisition of Valley Agriceuticals.

The state has also announced that Valley Agriceuticals has officially been granted a license as a Registered Organization under the medical marijuana program of the State of New York.

More details can be found here.

iAnthus was in the news recently when the company said it was expanding into the New York State market after signing a binding letter of intent to acquire 100% of Valley Agriceuticals, LLC.

By doing so, the company says it will gain exposure to 20 million residents in the rapidly growing Medical Marijuana market in New York State.

Valley Agriceuticals has received conditional approval from the New York State Department of Health to be awarded one of just 10 medical marijuana medical licenses issued by the state.

Full Disclosure: iAnthus Capital Holdings Inc. is a paid client of Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company